{"success":true,"data":{"pressRelease":{"id":"162690","rtpr_id":"nGNE5kkm8l-20261007","ticker":"AMSU","exchange":"LSE","all_tickers":["AMSU"],"title":"REG-Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 06 10 2026] - (CGWL)","author":"Globe Newswire","published_at":"2026-10-07T08:02:47.077Z","article_body":"FORM 8.3\n\nPUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY \nA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE\nRule 8.3 of the Takeover Code (the “Code”)\n\n1.        KEY INFORMATION\n\n (a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients) \n (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A \n (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC \n (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A \n (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 06 OCTOBER 2026 \n (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A” N/A \n\n2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE\n\nIf there are positions or rights to subscribe to disclose in more than one\nclass of relevant securities of the offeror or offeree named in 1(c), copy\ntable 2(a) or (b) (as appropriate) for each additional class of relevant\nsecurity.\n\n(a)      Interests and short positions in the relevant securities of the\nofferor or offeree to which the disclosure relates following the dealing (if\nany)\n\n Class of relevant security: 5p ORDINARY \n Interests Short positions \n Number % Number % \n (1) Relevant securities owned and/or controlled: 9,022,375 4.0843 \n (2) Cash-settled derivatives: \n (3) Stock-settled derivatives (including options) and agreements to purchase/sell: \n TOTAL: 9,022,375 4.0843 \n\nAll interests and all short positions should be disclosed.\n\nDetails of any open stock-settled derivative positions (including traded\noptions), or agreements to purchase or sell relevant securities, should be\ngiven on a Supplemental Form 8 (Open Positions).\n\n(b)      Rights to subscribe for new securities (including directors’\nand other employee options)\n\n Class of relevant security in relation to which subscription right exists: \n Details, including nature of the rights concerned and relevant percentages: \n\n3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE\n\nWhere there have been dealings in more than one class of relevant securities\nof the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as\nappropriate) for each additional class of relevant security dealt in.\n\nThe currency of all prices and other monetary amounts should be stated.\n\n(a)        Purchases and sales\n\n Class of relevant security Purchase/sale Number of securities Price per unit \n 5p ORDINARY SALE 4,459 282.01p \n\n(b)        Cash-settled derivative transactions\n\n Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit \n NONE \n\n(c)        Stock-settled derivative transactions (including options)\n\n(i)        Writing, selling, purchasing or varying\n\n Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit \n NONE \n\n(ii)        Exercise\n\n Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit \n\n(d)        Other dealings (including subscribing for new securities)\n\n Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) \n NONE \n\n4.        OTHER INFORMATION\n\n(a)        Indemnity and other dealing arrangements\n\n Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none” \n NONE \n\n(b)        Agreements, arrangements or understandings relating to\noptions or derivatives\n\n Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none” \n NONE \n\n(c)        Attachments\n\n Is a Supplemental Form 8 (Open Positions) attached? NO \n\n\n\n Date of disclosure: 07 OCTOBER 2026 \n Contact name: PHIL HULME \n Telephone number: 01253 376551 \n\nPublic disclosures under Rule 8 of the Code must be made to a Regulatory\nInformation Service.\n\nThe Panel’s Market Surveillance Unit is available for consultation in\nrelation to the Code’s disclosure requirements on +44 (0)20 7638 0129.\n\nThe Code can be viewed on the Panel’s website at\nwww.thetakeoverpanel.org.uk.","article_body_html":"","raw_payload":{"data":{"id":"nGNE5kkm8l-20261007","title":"REG-Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 06 10 2026] - (CGWL)","author":"Globe Newswire","ticker":"AMSU","created":"2026-10-07T08:02:47.077Z","tickers":["AMSU"],"exchange":"LSE","article_body":"FORM 8.3\n\nPUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY \nA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE\nRule 8.3 of the Takeover Code (the “Code”)\n\n1.        KEY INFORMATION\n\n (a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients) \n (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A \n (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC \n (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A \n (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 06 OCTOBER 2026 \n (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A” N/A \n\n2.        POSITIONS OF THE PERSON MAKING THE DISCLOSURE\n\nIf there are positions or rights to subscribe to disclose in more than one\nclass of relevant securities of the offeror or offeree named in 1(c), copy\ntable 2(a) or (b) (as appropriate) for each additional class of relevant\nsecurity.\n\n(a)      Interests and short positions in the relevant securities of the\nofferor or offeree to which the disclosure relates following the dealing (if\nany)\n\n Class of relevant security: 5p ORDINARY \n Interests Short positions \n Number % Number % \n (1) Relevant securities owned and/or controlled: 9,022,375 4.0843 \n (2) Cash-settled derivatives: \n (3) Stock-settled derivatives (including options) and agreements to purchase/sell: \n TOTAL: 9,022,375 4.0843 \n\nAll interests and all short positions should be disclosed.\n\nDetails of any open stock-settled derivative positions (including traded\noptions), or agreements to purchase or sell relevant securities, should be\ngiven on a Supplemental Form 8 (Open Positions).\n\n(b)      Rights to subscribe for new securities (including directors’\nand other employee options)\n\n Class of relevant security in relation to which subscription right exists: \n Details, including nature of the rights concerned and relevant percentages: \n\n3.        DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE\n\nWhere there have been dealings in more than one class of relevant securities\nof the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as\nappropriate) for each additional class of relevant security dealt in.\n\nThe currency of all prices and other monetary amounts should be stated.\n\n(a)        Purchases and sales\n\n Class of relevant security Purchase/sale Number of securities Price per unit \n 5p ORDINARY SALE 4,459 282.01p \n\n(b)        Cash-settled derivative transactions\n\n Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit \n NONE \n\n(c)        Stock-settled derivative transactions (including options)\n\n(i)        Writing, selling, purchasing or varying\n\n Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit \n NONE \n\n(ii)        Exercise\n\n Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit \n\n(d)        Other dealings (including subscribing for new securities)\n\n Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) \n NONE \n\n4.        OTHER INFORMATION\n\n(a)        Indemnity and other dealing arrangements\n\n Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none” \n NONE \n\n(b)        Agreements, arrangements or understandings relating to\noptions or derivatives\n\n Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none” \n NONE \n\n(c)        Attachments\n\n Is a Supplemental Form 8 (Open Positions) attached? NO \n\n\n\n Date of disclosure: 07 OCTOBER 2026 \n Contact name: PHIL HULME \n Telephone number: 01253 376551 \n\nPublic disclosures under Rule 8 of the Code must be made to a Regulatory\nInformation Service.\n\nThe Panel’s Market Surveillance Unit is available for consultation in\nrelation to the Code’s disclosure requirements on +44 (0)20 7638 0129.\n\nThe Code can be viewed on the Panel’s website at\nwww.thetakeoverpanel.org.uk."},"type":"article","timestamp":"2026-10-07T08:02:47.187303014Z","server_sent_at_ms":1791360167187},"received_at":"2026-10-07T08:02:47.238Z","source_url":null},"analysis":{"id":"151170","press_release_id":"162690","analysis_json":{"industry":{"label":"Health Care Equipment & Supplies","sector":"Health Care"},"redFlags":[],"eventType":"regulatory","narrative":"Canaccord Genuity Wealth Limited filed a Rule 8.3 Takeover Code disclosure showing interests of 9,022,375 shares, or 4.0843%, in Advanced Medical Solutions Group as of October 6, 2026.\n\nThe filing discloses a single sale of 4,459 shares at 282.01p per share, with no derivative positions or indemnity arrangements.\n\nThis is a routine regulatory position disclosure, not an issuer announcement, though its Rule 8.3 context indicates an offer or possible offer for the company exists.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine Rule 8.3 institutional position disclosure -- suppress unless tracking takeover offer positioning."},"keyFigures":{"customDimensions":{"sale_price":"282.01p","shares_sold":4459,"shares_owned":9022375,"ownership_percent":"4.0843%"}},"namedEntities":{"people":[{"name":"Phil Hulme","role":"disclosure contact"}],"products":["5p Ordinary shares"],"companies":[{"name":"Canaccord Genuity Wealth Limited","relationship":"discloser / shareholder"},{"name":"Advanced Medical Solutions Group PLC","ticker":"AMSU","relationship":"subject company (offeree)"}],"dollarAmounts":[{"amount":"282.01p","context":"price per share of 4,459-share sale"}]},"materialImpact":{"score":1,"reasoning":"Routine UK Takeover Code Rule 8.3 position disclosure by Canaccord Genuity Wealth Limited regarding its ~4.08% stake in Advanced Medical Solutions Group. Boilerplate regulatory filing with a minor sale of 4,459 shares; no new issuer information."},"tickerRelevance":{"others":[],"primary":"AMSU"},"globalImportance":8,"audienceRelevance":10,"eventTypeSecondary":["other"],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"routine-takeover-code-disclosure","issuerAuthored":false}},"event_type":"regulatory","event_type_secondary":["other"],"sentiment":"neutral","material_impact_score":1,"narrative":"Canaccord Genuity Wealth Limited filed a Rule 8.3 Takeover Code disclosure showing interests of 9,022,375 shares, or 4.0843%, in Advanced Medical Solutions Group as of October 6, 2026.\n\nThe filing discloses a single sale of 4,459 shares at 282.01p per share, with no derivative positions or indemnity arrangements.\n\nThis is a routine regulatory position disclosure, not an issuer announcement, though its Rule 8.3 context indicates an offer or possible offer for the company exists.","key_figures":{"customDimensions":{"sale_price":"282.01p","shares_sold":4459,"shares_owned":9022375,"ownership_percent":"4.0843%"}},"named_entities":{"people":[{"name":"Phil Hulme","role":"disclosure contact"}],"products":["5p Ordinary shares"],"companies":[{"name":"Canaccord Genuity Wealth Limited","relationship":"discloser / shareholder"},{"name":"Advanced Medical Solutions Group PLC","ticker":"AMSU","relationship":"subject company (offeree)"}],"dollarAmounts":[{"amount":"282.01p","context":"price per share of 4,459-share sale"}]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-07T08:02:52.982Z","global_importance":8,"audience_relevance":10,"importance_components":{"tickerTier":"small-cap","eventGravity":"routine-takeover-code-disclosure","issuerAuthored":false}},"durationMs":5735,"modelName":"glm-5.3-flashx"}}